Tempest Therapeutics, Inc. says some leaders are leaving, while new ones are being chosen and hired.

Oct 19, 2026, 5:56 PM ETNew bossRead the original at SEC EDGAR

Neutral

Tempest's filing lists a section about officer and director changes, but the supplied text gives no names or details. It does not show how the changes affect the company, so the outlook stays unchanged.

TPST · Tempest Therapeutics, Inc.

AI read · Neutral

The AI's read

The text names a section about officer and director changes, but does not say who changed roles or what they will receive. With no details about the changes or their effect on the business, the filing gives no clear reason to change Tempest's outlook.

Get alerts for TPST

Follow Tempest Therapeutics, Inc. (TPST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TPST

Free on the App Store and Google Play, or on the web.